These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6835236)

  • 1. Evaluation of epichlorohydrin (ECH) genotoxicity. Microsomal epoxide hydrolase-dependent deactivation of ECH mutagenicity in Schizosaccharomyces pombe in vitro.
    Rossi AM; Migliore L; Loprieno N; Romano M; Salmona M
    Mutat Res; 1983 Apr; 109(1):41-52. PubMed ID: 6835236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity, metabolism and blood kinetics of epichlorohydrin in mice.
    Rossi AM; Migliore L; Lascialfari D; Sbrana I; Loprieno N; Tortoreto M; Bidoli F; Pantarotto C
    Mutat Res; 1983 Aug; 118(3):213-26. PubMed ID: 6877269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic relevance of rat hepatocyte nuclei in the activation and inactivation of xenobiotica. Cyclophosphamide and epichlorohydrin activity on the yeasts S. pombe and S. cerevisiae.
    Migliore L; Rossi AM; Loprieno N; Romano M; Salmona M
    Mutat Res; 1983 Nov; 111(3):313-23. PubMed ID: 6358879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro mutagenicity studies of a possible carcinogen, trichloroethylene, and its two stabilizers, epichlorohydrin and 1,2-epoxybutane.
    Rossi AM; Migliore L; Barale R; Loprieno N
    Teratog Carcinog Mutagen; 1983; 3(1):75-87. PubMed ID: 6132459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro induction of SCE in human lymphocytes by epichlorohydrin with and without metabolic activation.
    White AD
    Mutat Res; 1980 Jun; 78(2):171-6. PubMed ID: 7393244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
    Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
    Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hepatic microsomal and cytosolic subcellular fractions on the mutagenic activity of epoxide-containing compounds in the Salmonella assay.
    El-Tantawy MA; Hammock BD
    Mutat Res; 1980 Sep; 79(1):59-71. PubMed ID: 7001221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on metabolism and toxicity of styrene: III. The effect of metabolic inactivation by rat-liver S9 on the mutagenicity of phenyloxirane toward Salmonella typhimurium.
    Yoshikawa K; Isobe M; Watabe I; Takabatake E
    Mutat Res; 1980 Jul; 78(3):219-26. PubMed ID: 7001214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the mutagenicity of three dinitropyrene isomers in vitro by rat-liver S9, cytosolic, and microsomal fractions following chronic ethanol ingestion.
    Winston GW; Traynor CA; Shane BS; Hajos AK
    Mutat Res; 1992 Jun; 279(4):289-98. PubMed ID: 1377785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.
    De Flora S; Morelli A; Basso C; Romano M; Serra D; De Flora A
    Cancer Res; 1985 Jul; 45(7):3188-96. PubMed ID: 4005852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of drug metabolizing enzymes during the incubation conditions of the liver microsomal assay with non-induced and induced mouse liver S-9 fractions.
    Paolini M; Tonelli F; Bauer C; Corsi C; Bronzetti G
    Carcinogenesis; 1987 Sep; 8(9):1179-84. PubMed ID: 3113750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
    Walters JM; Combes RD
    Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ distribution of epoxide hydrolases in cytosolic and microsomal fractions of normal and nafenopin-treated male DBA/2 mice.
    Waechter F; Bentley P; Bieri F; Muakkassah-Kelly S; Stäubli W; Villermain M
    Biochem Pharmacol; 1988 Oct; 37(20):3897-903. PubMed ID: 3190736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of short-term tests for mutagenicity: on the optimal pH for the liver microsomal assay.
    Paolini M; Sapigni E; Hrelia P; Grilli S; Lattanzi G; Cantelli-Forti G
    Carcinogenesis; 1988 Dec; 9(12):2265-70. PubMed ID: 3191571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of some organophosphorus compounds at the ade6 locus of Schizosaccharomyces pombe.
    Gilot-Delhalle J; Colizzi A; Moutschen J; Moutschen-Dahmen M
    Mutat Res; 1983 Apr; 117(1-2):139-48. PubMed ID: 6835257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic action of structurally related alkene oxides on Schizosaccharomyces pombe: the influence, 'in vitro', of mouse-liver metabolizing system.
    Migliore L; Rossi AM; Loprieno N
    Mutat Res; 1982 Dec; 102(4):425-37. PubMed ID: 7177150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of human liver cytosolic epoxide hydrolase and comparison to the microsomal enzyme.
    Wang P; Meijer J; Guengerich FP
    Biochemistry; 1982 Nov; 21(23):5769-76. PubMed ID: 6185139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective hydrolysis of racemic epichlorohydrin using an epoxide hydrolase from Novosphingobium aromaticivorans.
    Woo JH; Hwang YO; Kang JH; Lee HS; Kim SJ; Kang SG
    J Biosci Bioeng; 2010 Sep; 110(3):295-7. PubMed ID: 20547378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
    Buckpitt AR; Bahnson LS; Franklin RB
    J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways.
    Oesch F; Bücker M; Glatt HR
    Mutat Res; 1981 Mar; 81(1):1-10. PubMed ID: 7019683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.